SEC Form 4 · accession 0000904454-15-000509
GENOCEA BIOSCIENCES, INC. · GNCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Seth V Hetherington
Officer — Chief Medical Officer
Period of report
Aug 7, 2015
Accepted (ET)
Aug 11, 2015 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001457612
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 7, 2015 | M | 2,989 | $2.02 | A | 13,989 | D | |
| Common Stock | Aug 7, 2015 | M | 2,011 | $2.02 | A | 16,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.02 | Aug 7, 2015 | M | 2,989 | D | — | Feb 17, 2021 | Common Stock | 2,989 | 11,562 | D |
| Stock Option (Right to Buy)F1 | $2.02 | Aug 7, 2015 | M | 2,011 | D | — | Feb 17, 2021 | Common Stock | 2,011 | 71,955 | D |
Explanation of responses
- F1The option was granted on 2/17/2011 and the vesting schedule was completed in February 2015.